Unknown

Dataset Information

0

Serum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses.

ABSTRACT: We examined serum samples from adults ages 48-64 who received multiple seasonal influenza vaccines from 2004 to 2009 for cross-neutralizing antibodies to potential pandemic strains. Using pseudoviruses bearing various hemagglutinins (HA-pseudoviruses), we found serum neutralization titers (?160) in 100% against A/Japan/305/1957 (H2N2), 53% against A/Hong Kong/1073/99 (H9N2), 56% against the H3N2 variant A/Indiana/08/11 (H3N2v), 11% against A/Hong Kong/G9/97 (H9N2), and 36% A/chicken/Hong Kong/SF4/01 (H6N1). None had titers >160 to A/Shanghai/2/13 (H7N9) or A/Netherlands/219/03 (H7N7). Thirty-six percent to 0% had neutralization titers to various H5N1 strains. Titers to H9, H6, and H5 HA-pseudoviruses correlated with each other, but not with H3N2v, suggesting group-specific cross-neutralization.

SUBMITTER: Wang W 

PROVIDER: S-EPMC7313900 | biostudies-literature | 2016 Feb

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Serum Samples From Middle-aged Adults Vaccinated Annually with Seasonal Influenza Vaccines Cross-neutralize Some Potential Pandemic Influenza Viruses.

Wang Wei W   Alvarado-Facundo Esmeralda E   Chen Qiong Q   Anderson Christine M CM   Scott Dorothy D   Vassell Russell R   Weiss Carol D CD  

The Journal of infectious diseases 20150804 3

We examined serum samples from adults ages 48-64 who received multiple seasonal influenza vaccines from 2004 to 2009 for cross-neutralizing antibodies to potential pandemic strains. Using pseudoviruses bearing various hemagglutinins (HA-pseudoviruses), we found serum neutralization titers (≥160) in 100% against A/Japan/305/1957 (H2N2), 53% against A/Hong Kong/1073/99 (H9N2), 56% against the H3N2 variant A/Indiana/08/11 (H3N2v), 11% against A/Hong Kong/G9/97 (H9N2), and 36% A/chicken/Hong Kong/SF  ...[more]

Similar Datasets

Unknown Improving seasonal and pandemic influenza vaccines.
| S-EPMC4634120 | biostudies-other
Unknown Responses to A(H1N1)pdm09 influenza vaccines in participants previously vaccinated with seasonal influenza vaccine: a randomized, observer-blind, controlled study.
| S-EPMC4195439 | biostudies-literature
Unknown Next generation methodology for updating HA vaccines against emerging human seasonal influenza A(H3N2) viruses.
| S-EPMC7925519 | biostudies-literature
Unknown Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses.
| S-EPMC3784541 | biostudies-literature
Unknown Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses
| S-EPMC3809818 | biostudies-literature
Unknown MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis.
| S-EPMC4634121 | biostudies-other
Unknown An Overview of Influenza Viruses and Vaccines.
| S-EPMC8473132 | biostudies-literature
Unknown Elderly people: propensity to be vaccinated for seasonal influenza in Italy.
| S-EPMC7482847 | biostudies-literature
Unknown Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses.
| S-EPMC4978566 | biostudies-literature
Unknown Epidemiology of seasonal influenza in the Middle East and North Africa regions, 2010-2016: Circulating influenza A and B viruses and spatial timing of epidemics.
| S-EPMC5907816 | biostudies-other